Equity
€792,302 ▼ 17.3%
APOTHEEK paid out €300,000 in dividends. That is 224% of the 2025 profit.
APOTHEEK BEELE-LAMOTE
Lifetime
20 annual accounts with figures on one time axis, 38 filings since 1988peak €212,256 (2025)
€212,256▲ 12.0%
lowest -€53,055 (2006)
€133,810▲ 20.7%
peak €1.3m (2023)
€792,302▼ 17.3%
€592,503▲ 79.2%
peak 0.5 FTE (2006)
0.2 FTEunchanged
Board5 names since 2018
-
Owners
99.87%
Documentsfilings and deeds
30-06-202631 days before the deadline
2025abbreviated format
Gross margin from €189,455 to €212,256Dividend €300,000Equity from €958,492 to €792,302Debts from €330,725 to €592,503
Key points
from the 2025 annual accountsTurnover
≈ €1.0m estimated
The abbreviated format states no turnover.
Debts
€592,503 ▲ 79.2%
Debts rose by €261,778 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.
Staff
2 employees on 31-12-2025
In 2025, 1 person joined and nobody left.
Liquidity
2.52 was 5.01 in 2024
Short-term debts rose from €238,641 to €520,688.
Filings
38 annual accounts since 1988
Three of the last ten came late. The 2017 accounts came latest: 28 days after the end of the period.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 31,386 companies had the same profile as APOTHEEK BEELE-LAMOTE has now. Each dot stands for 79 companies, two years later.
93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,386 companies, not a prediction for APOTHEEK BEELE-LAMOTE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
last known boardDirector, until 2022
Director, until 2022
Director, until 2022
- 99.87%equity €1.1m (2025) · 2025 annual accounts of
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0433625038
Company renamed from APOTEEK to APOTHEEK
Change of role: , from director to sole director · Resignations: (managing director) and (managing director) · Permanent representatives: and · General meeting of 13-04-2022 · Gazette deed
3 directors reappointed
(managing director), (managing director) and · Permanent representative: · General meeting of 28-06-2018 · Gazette deed
First establishment
Apotheek , Salinusstraat 1, Wevelgem
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| APOTHEEK BEELE-LAMOTE Wevelgem | €1.4m | €212,256 | 57.2% | 0.2 |
| APOTHEEK VAN DAMME Bruges | €1.6m | €230,995 | 33.7% | 0.3 |
| APOTHEEK BORMANS BOVELINGEN Heers | €1.3m | €207,810 | 6.1% | 0.2 |
| FARMA KOERSEL Beringen | €1.6m | €239,953 | 11.3% | 0.1 |
| APOTHEEK COSSEY-HOUSSIN Wevelgem | €1.6m | €253,087 | 21.7% | 0 |
| FAMARO Tongeren-Borgloon | €1.2m | €190,250 | 89.3% | 0 |
| A-CURA Beringen | €1.0m | €248,911 | 28.1% | 0.3 |
These companies have the same main activity as APOTHEEK : retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1m and €1.6m, founded between 1983 and 1997.
Official details
Source: KBO- Status
- Active since 10-03-1988Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment unit
- 2.036.303.6778560 Wevelgem, since 25-03-1988
- Financial year end
- 31 December
- Peppol
- Reachable since 25-10-2024
Annual accounts 2025
- €1.4m▲ 7.4%
- Employeeson 31-12-2025
- 2▲ 100%
- Filing
- Filed on 30-06-2026, 31 days before the end of the filing period
Insights on APOTHEEK BEELE-LAMOTE
APOTHEEK files the abbreviated format. That format states no turnover. The gross margin rose from -€31,184 in 2006 to €212,256 in 2025.
holds all the shares. In May 2022, three directors stepped down.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about APOTHEEK BEELE-LAMOTE
- What is the company number of APOTHEEK BEELE-LAMOTE?
- The company number of APOTHEEK is 0433.625.038. The VAT number is the same number with BE in front: BE 0433.625.038.
- Where is APOTHEEK BEELE-LAMOTE based?
- The registered office is at Salinusstraat 1, 8560 Wevelgem.Company details
- What does APOTHEEK BEELE-LAMOTE do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK BEELE-LAMOTE?
- APOTHEEK is a public limited company (NV).
- When was APOTHEEK BEELE-LAMOTE founded?
- APOTHEEK was founded on 10-03-1988.
- Is APOTHEEK BEELE-LAMOTE still active?
- Yes, APOTHEEK is an active enterprise in the KBO register.
- How many employees does APOTHEEK BEELE-LAMOTE have?
- APOTHEEK had an average of 0.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does APOTHEEK BEELE-LAMOTE fall under?
- In its 2025 annual accounts, APOTHEEK states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of APOTHEEK BEELE-LAMOTE?
- The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €212,256 and 43 comparable companies (NACE 477). It probably lies between €650,000 and €2.1m.
- Is APOTHEEK BEELE-LAMOTE profitable?
- In financial year 2025, APOTHEEK made a profit of €133,810.
- Where can I find the annual accounts of APOTHEEK BEELE-LAMOTE?
- APOTHEEK filed 38 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APOTHEEK BEELE-LAMOTE due?
- APOTHEEK must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.